MaselsMasernSarrampi%C3%B3n%D8%AD%D8%B5%D8%A8%D8%A9%E0%A6%B8%E0%A7%B0%E0%A7%81%E0%A6%86%E0%A6%87Sarampi%C3%B3nPiyampiya_usuQ%C4%B1z%C4%B1lca_(x%C9%99st%C9%99lik)%D2%A0%D1%8B%D2%99%D1%8B%D0%BB%D1%81%D0%B0_(%D0%B0%D1%83%D1%8B%D1%80%D1%8B%D1%83)%D0%90%D0%B4%D0%B7%D1%91%D1%80%D0%90%D0%B4%D0%B7%D1%91%D1%80%D0%94%D1%80%D0%B5%D0%B1%D0%BD%D0%B0_%D1%88%D0%B0%D1%80%D0%BA%D0%B0%E0%A4%96%E0%A4%B8%E0%A4%B0%E0%A4%BE_%E0%A4%B0%E0%A5%8B%E0%A4%97Karumut%E0%A6%B9%E0%A6%BE%E0%A6%AE%E0%BD%A6%E0%BD%B2%E0%BD%96%E0%BC%8B%E0%BD%96%E0%BD%B2%E0%BC%8DRuzellXarampi%C3%B3%D8%B3%D9%88%D8%B1%DB%8E%DA%98%DB%95MeaslesSpalni%C4%8DkyW%C3%ABs%C3%ABpnica%D0%A5%C4%95%D1%80%D0%BB%C4%95%D1%85%D0%B5%D0%BDBrech_gochM%C3%A6slingerKategorie:MasernMasernAju%C3%ABk%DE%80%DE%A8%DE%89%DE%A6%DE%84%DE%A8%DE%80%DE%A8%CE%99%CE%BB%CE%B1%CF%81%CE%ACF%C3%A8rsMeaslesMeaslesMorbiloSarampi%C3%B3nLeetridElgorri%D8%B3%D8%B1%D8%AE%DA%A9TuhkarokkoRougeole
about
Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) VaccineThe Influence of Probiotics on the Immunologic Response to Vaccinations in InfantsImmunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersImmunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenStudy of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of AgeReactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and ChildrenA Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of AgeSafety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A VaccineInduction of Immunity Against Measles in Pediatric Liver Transplant RecipientsImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeTrial of Additional Measles Vaccine to Reduce Child MortalityImmunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive FactorsStudy to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and RubellaImmune Reconstitution to Measles Virus of HIV Infected Children in ZambiaImmunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderEarly Waning of Maternal Measles and Meningitis C AntibodiesUARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles VirusSafety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeStudy to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and RubellaSafety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the PhilippinesConsistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of AgeCoadministration of Measles-rubella and Rotavirus VaccinesImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeTrial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different DevicesAdditional Measles Vaccine at 4 Months of AgeMaking Decisions About the Measles-Mumps-Rubella VaccineProQuad Dose Selection Study (V221-011)(COMPLETED)A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMSeroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable DiseaseImmunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working SeedsStudy of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersMeasles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung CancerA Study of ProQuad™ in Healthy Children in Korea (V221-023)
P1050
P1542
P1995
P301
Louis, Dauphin of France, Duke of BurgundyMajid bin Sa'ud Al Sa'udArnaqLouis, Dauphin of France, Duke of BrittanyMarie Adélaïde of SavoyHenry LukinNatalia PetrovnaCharles Orlando, Dauphin of FranceCéline MontalandTokugawa TsunayoshiKamāmaluCharlotte of ValoisKamehameha IILudmilla Elisabeth of Schwarzburg-RudolstadtIsrael LyonsGeneviève de MalboissièreDaniel GreathouseEagle of DelightHenry Dalzell, 8th Earl of CarnwathKaiminaauaoHenry GibbsOlivia DahlPrince Henry of the NetherlandsNapoleon Louis BonaparteTe RangihaeataMaeda ShigenobuMarjory EdwardsManuelito
P509
description
Bekende kindersiekte wat steeds in epidemies in ontwikkelende lande voorkom
@af
Doença viral
@pt
choroba wirusowa człowieka
@pl
durch das Masernvirus hervorgerufene, hoch ansteckende Infektionskrankheit
@de
enfermedad infecciosa con erupción cutánea
@es
infekční onemocnění
@cs
maladie infectieuse virale
@fr
malaltia molt contagiosa que afecta sobretot els infants
@ca
malattia umana virale
@it
nakkushaigus
@et
name
7ecba
@aeb-latn
Ajuëk
@din
Akpata
@ig
An Bhruitíneach
@ga
Elgorri
@eu
Ermizolu
@sc
Fers
@lmo
Fruthi
@sq
Fèrs
@eml
Gabagen
@map-bms
type
label
7ecba
@aeb-latn
Ajuëk
@din
Akpata
@ig
An Bhruitíneach
@ga
Elgorri
@eu
Ermizolu
@sc
Fers
@lmo
Fruthi
@sq
Fèrs
@eml
Gabagen
@map-bms
altLabel
Bệnh phong chẩn
@vi
Bệnh rubeola
@vi
Bệnh sởi
@vi
Demam campak
@ms
Ière maladie
@fr
Koplik-Flecken
@de
Koplikflecken
@de
Male boginje
@sh
Measles virus infectious disease
@en
Measles
@ml
prefLabel
7ecba
@aeb-latn
Ajuëk
@din
Akpata
@ig
An Bhruitíneach
@ga
Elgorri
@eu
Ermizolu
@sc
Fers
@lmo
Fruthi
@sq
Fèrs
@eml
Gabagen
@map-bms